Cosmo announces successful Phase III clinical trial of Lumeblue™ in China
Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced the successful phase III clinical trial of Lumeblue™ in China, sponsored by its partner China Medical System Holdings Limited (CMS) (867.HK).